New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its.
EyePoint Pharmaceuticals Appoints Jay S. Duker, M.D. as Chief Operating Officer - read this article along with other careers information, tips and advice on BioSpace